Download PDF
Hamostaseologie 1986; 06(05): 180-192
DOI: 10.1055/s-0038-1655158
Originalarbeiten
Schattauer GmbH

Niedermolekulare Heparine Eine Übersicht über Wirkprofil und bisherige klinische Anwendung

S. Haas
1   Institut für Experimentelle Chirurgie (Direktor: Prof. Dr. med. G. Blümel) der Technischen Universität München
,
P. Haas
1   Institut für Experimentelle Chirurgie (Direktor: Prof. Dr. med. G. Blümel) der Technischen Universität München
,
G. Blümel
1   Institut für Experimentelle Chirurgie (Direktor: Prof. Dr. med. G. Blümel) der Technischen Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
25 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Abildgaard U. Purification of two progressive antithrombins of human plasma. Scand J clin Lab Invest 1967; 19: 190-5.
    CrossrefPubMedSearch in Google Scholar
  • 2 Aillaud M F, Elias A, Alessi M C, Lecorf G, Bouvier J L, Roul C, Serradimigni A, Juhan-Vague I. Treatment of deep vein thrombosis (DVT) with LMWH CY 222. Thrombolysis and plasma fibrinolytic parameters. Fibrinolysis. Abstr. 179, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 3 Andersson L O, Barrowcliffe T W, Holmer E, Johnson E A, Sims G E C. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 09: 575-83.
    CrossrefPubMedSearch in Google Scholar
  • 4 Andersson L O, Barrowcliffe T W, Holmer E, Johnson E A, Söderström G. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. Thromb Res 1979; 15: 531-41.
    CrossrefPubMedSearch in Google Scholar
  • 5 Bagge L, Nyström S O, Tydén H, Holmer E, Malm T, Wahlberg T. Coagulation and fibrinolysis when using fragmin during cardiopulmonary by-pass (CPB) in vitro and in vivo. Fibrinolysis. Abstr. 181, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 6 Barbanti M, Mastacchi R, Bianchini P. Systemic fibrinolytic activity of sulfated polysaccharides. Fibrinolysis. Abstr. 331, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 7 Barrowcliffe T W, Johnson E A, Eggleton C A, Kemball-Cook G, Thomas D P. Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol 1979; 41: 573-83.
    CrossrefPubMedSearch in Google Scholar
  • 8 Barrowcliffe T W, Merton R E, Havercroft S J, Thunberg L, Lindahl U, Thomas D P. Low affinity heparin potentiates the action of high affinity heparin oligosaccharides. Thromb Haemost 1983; 50: 183 (Abstr).
    PubMedSearch in Google Scholar
  • 9 Bengtsson G, Olivecrona T. Interaction of lipoprotein lipase with heparin-sepharose. Evaluation of conditions for affinity binding. Biochem J 1977; 167: 109-19.
    CrossrefPubMedSearch in Google Scholar
  • 10 Bengtsson G, Olivecrona T, Höök M, Lindahl U. Interaction of heparin with proteins. Demonstration of different binding sites for antithrombin and lipoprotein lipase. FEBS Lett 1977; 79: 59-63.
    CrossrefPubMedSearch in Google Scholar
  • 11 Bengtsson G, Olivecrona T, Höök M, Riesenfeld J, Lindahl U. Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J 1980; 189: 625-33.
    CrossrefPubMedSearch in Google Scholar
  • 12 Bergqvist D, Burmark U S, Frisell J, Hallböök T, Lindblad B, Risberg B, Törngren S, Wallin G. Prospective doubleblind comparison between fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications. Haemostasis 1986; 16 (Suppl. 02) 11-8.
    PubMedSearch in Google Scholar
  • 13 Binsack T, Zellner M, Schimming I, Wirth C, Moser E, Riess H, Hiller E. Thrombosis prophylaxis with LMW heparin and sodium heparin in patients with total hip replacement. Thromb Res 1986; Suppl VI: 83 (Abstr).
    PubMedSearch in Google Scholar
  • 14 Boneu B, Bemecheckroun S, Goudable C, Sié P. Heparin pharmacokinetics in deep vein thrombosis. Thromb Res 1986; Suppl VI: 89 (Abstr).
    PubMedSearch in Google Scholar
  • 15 Borm J J J, Krediet R, Sturk A, ten Cate J W. Heparin versus low molecular weight heparin K 2165 in chronic hemodialysis patients: a randomized cross-over study. Haemostasis 1986; 16 (Suppl. 02) 59-68.
    PubMedSearch in Google Scholar
  • 16 Bratt G, Törnebohm E, Granqvist S, Åberg W, Lockner D. A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Thromb Haemost 1985; 54: 813-7.
    Thieme ConnectPubMedSearch in Google Scholar
  • 17 Breyer H G, Al-Therib J, Bacher P, Werner B. Thrombosis prophylaxis with low molecular weight heparin in trauma surgery. Thromb Res 1986; Suppl VI: 84 (Abstr).
    PubMedSearch in Google Scholar
  • 18 Carter C J, Kelton J G, Hirsh J, Gent M. Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thromb Res 1981; 21: 169-74.
    CrossrefPubMedSearch in Google Scholar
  • 19 Carter C J, Kelton J G, Hirsh J, Cerskus A, Santos A V, Gent M. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 1982; 59: 1239-45.
    PubMedSearch in Google Scholar
  • 20 Choay J, Lormeau J C, Petitou M, Sinay P, Casu B, Oreste P, Torri G, Gatti G. AntiXa active heparin oligosaccharides. Thromb Res 1980; 18: 573-8.
    CrossrefPubMedSearch in Google Scholar
  • 21 Choay J, Lormeau J C, Petitou M, Torri G, Sinay P. Physico-chemical studies on oligosaccharides from porcine mucosal heparin. Thromb Haemost 1981; 46: 236 (Abstr).
    Thieme ConnectPubMedSearch in Google Scholar
  • 22 Choay J, Lormeau J C, Petitou M. Physical, chemical, biological characteristics and sequence of the antithrombin III binding site of the heparin low molecular weight fraction CY 216. Haemostasis 1982; 12: 219 (Abstr).
    PubMedSearch in Google Scholar
  • 23 Choay J, Fareed J, Andersen A, Stulc J, Ward M. Studies on the antithrombotic action of a low molecular weight heparin fraction in a stasis thrombosis rabbit model. Fed Proc 1982; 41: 919 (Abstr).
    PubMedSearch in Google Scholar
  • 24 Danishefsky I, Radoff S. Location of the anticoagulant-conferring area on the heparin chain. Thromb Haemost 1983; 50: 102 (Abstr).
    Thieme ConnectPubMedSearch in Google Scholar
  • 25 Doutremepuich C, Gestreau J L, Maury M O, Quilichini R, Boisseau M R, Toulemonde F, Vairel E. Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction. Haemostasis 1983; 13: 109-12.
    PubMedSearch in Google Scholar
  • 26 Dunn F, Soria J, Soria C, Thomaidis A, Tobelem G, Caen J P. Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate. Thromb Res 1983; 29: 141-8.
    CrossrefPubMedSearch in Google Scholar
  • 27 Einarsson R, Andersson L O. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochem Biophys Acta 1977; 490: 104-11.
    CrossrefPubMedSearch in Google Scholar
  • 28 Eriksson E, Wollter I M, Christenson B, Stigendal L, Risberg B. Enhancement of fibrinolysis by heparin. Fibrinolysis Abstr. 329, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 29 Esquivel C O, Bergqvist D, Björck C G, Nilsson B. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo. Thromb Res 1982; 28: 389-99.
    CrossrefPubMedSearch in Google Scholar
  • 30 Faivre R, Fareed J, Neuhart E, Kieffer Y, Petiteau P Y, Toulemonde F, Bassand J P, Maurat J P. Effects on clotting and fibrinolytic system of a low molecular weight heparin (CY 222) in patients with deep venous thrombosis. Preliminary result of a randomized trial. Fibrinolysis Abstr. 352, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 31 Fareed J, Kumar A, Walenga J M, Emanuele R M, Williamson K, Hoppensteadt D. Antithrombotic actions and pharmacokinetics of heparin fractions and fragments. Nouv Rev Fr Hematol 1984; 26: 267-75.
    PubMedSearch in Google Scholar
  • 32 Fareed J, Walenga J M, Williamsen K, Emanuele R M, Kumar A, Hoppensteadt D. Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments. Sem Thromb Hemost 1985; 11: 56-74.
    Thieme ConnectPubMedSearch in Google Scholar
  • 33 Fareed J. Heparin, its fractions, fragments and derivatives. Some newer perspectives. Sem Thromb Hemost 1985; 11: 1-9.
    Thieme ConnectPubMedSearch in Google Scholar
  • 34 Fareed J, Walenga J M, Hoppensteadt D A, Messmore H L. Studies on the profibrinolytic actions of heparin and its fractions. Sem Thromb Hemost 1985; 11: 199-207.
    Thieme ConnectPubMedSearch in Google Scholar
  • 35 Gensini G F, Fortini A, Lombardi A, Pesciullesi E, Pieroni C, Neri Serneri G. Binding of low-molecular-weight heparin to aortic endothelium in rabbits. Haemostasis 1984; 14: 466-72.
    PubMedSearch in Google Scholar
  • 36 Haas S, Stemberger A, Wendt P, Vinazzer H, Blümel G. The effects of low molecular weight heparin on various parameters of blood coagulation and fibrinolysis. Thromb Haemost 1983; 50: 224 (Abstr).
    Thieme ConnectPubMedSearch in Google Scholar
  • 37 Haas S, Fritsche H M, Hasner F, Stemberger A, Wendt P, Wolf H. Study of the anticoagulant and antithrombotic effect of low molecular weight heparin DHE (LMWH-DHE) in total hip replacement under double-blind conditions. Thromb Haemost 1985; 54: 92 (Abstr).
    PubMedSearch in Google Scholar
  • 38 Haas S, Stemberger A, Wendt P, Zeisel H J, Blümel G. Does low molecular weight heparin accumulate after repeated application?. Thromb Haemost 1985; 54: 34 (Abstr).
    PubMedSearch in Google Scholar
  • 39 Haas S, Fritsche H M, Stemberger A, Blümel G, Lechner F. Antithrombotische Wirksamkeit und Verträglichkeit des niedermolekularen Heparins Sandoz bei elektivem Hüftgelenkersatz. Acta Chir Austriaca 1986; 03: 380-1.
    PubMedSearch in Google Scholar
  • 40 Haas S, Fritsche H M, Stemberger A, Blümel G, Lechner F. Einfluß des niedermolekularen Heparins Fragmin® (KABI) auf die Blutgerinnung und postoperative Thrombose. Acta Chir Austriaca 1986; 03: 381-2.
    PubMedSearch in Google Scholar
  • 41 Harenberg J, de Vries J X. Characterization of heparins by high-performance size exclusion liquid chromatography. J Chromatogr 1983; 261: 287-92.
    CrossrefPubMedSearch in Google Scholar
  • 42 Harenberg J, Fussi F, Augustin J, Haberbosch W, Zimmermann R. Haemostatic and lipolytic effects of unfractionated and low molecular weight heparin. Thromb Haemost 1983; 50: 73.
    Thieme ConnectPubMedSearch in Google Scholar
  • 43 Holm H A, Ly B, Handeland G F, Abildgaard U, Arnesen K E, Gottschalk P, Hoeg V, Aandahl M, Haugen K, Laerum F, Scheel B, Sortland O, Vinje B. Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin. Haemostasis 1986; 16 (Suppl. 02) 30-7.
    PubMedSearch in Google Scholar
  • 44 Holmer E. Anticoagulant properties of heparin and heparin fractions. J Haematol 1980; 25 (Suppl. 036) 25-39.
    PubMedSearch in Google Scholar
  • 45 Holmer E, Lindahl U, Bäckström G, Thunberg L, Sandberg H, Söderström G, Andersson L O. Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res 1980; 18: 861-9.
    CrossrefPubMedSearch in Google Scholar
  • 46 Holmer E, Kurachi K, Söderström G. The molecular weight dependence of the rateenhancing effect of heparin on the inhibition of thrombin, Factor Xa, Factor IXa, Factor XIa, Factor Xlla and kallikrein by antithrombin. Biochem J 1981; 193: 395-400.
    CrossrefPubMedSearch in Google Scholar
  • 47 Holmer E, Mattsson C, Nilsson S. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits. Thromb Res 1982; 25: 475-86.
    CrossrefPubMedSearch in Google Scholar
  • 48 Holmer E, Bergqvist D, Hedner U. Anticoagulant effects in human volunteers after subcutaneous administration of heparin and of two types of low molecular weight heparin. Thromb Haemost 1983; 50: 91 (Abstr).
    Thieme ConnectPubMedSearch in Google Scholar
  • 49 Holmer E, Söderberg K, Bergqvist D, Lindahl U. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties. Haemostasis 1986; 16 (Suppl. 02) 1-7.
    PubMedSearch in Google Scholar
  • 50 Hoylaerts M, Holmer E, de Mol M, Collen D. Covalent complexes between low molecular weight heparin fragments and antithrombin III Inhibition kinetics and turnover parameters. Thromb Haemost 1983; 49: 109-15.
    Thieme ConnectPubMedSearch in Google Scholar
  • 51 Huisse M G, Guillin M C, Bezeaud A, Toulemonde F, Kitzis M, Andreassian B. Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions. Thromb Res 1982; 27: 485-90.
    CrossrefPubMedSearch in Google Scholar
  • 52 Johnson E A, Kirkwood T B L, Stirling Y, Perez-Requejo J L, Ingram G I C, Bangham D R, Brozovic M. Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection. Thromb Haemost 1976; 35: 586-91.
    Thieme ConnectPubMedSearch in Google Scholar
  • 53 Jordan R, Beeler D, Rosenberg R. Fractionation of low molecular weight heparin species and their interaction with antithrombin. J Biol Chem 1979; 254: 2902-13.
    PubMedSearch in Google Scholar
  • 54 Kakkar V V. The current status of lowdose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg 1978; 02: 3-18.
    CrossrefPubMedSearch in Google Scholar
  • 55 Kakkar V V, Bentley P G, Lawrence D, de Haas H A, Ward V P. Die Prophylaxe der postoperativen venösen Thromboembolie beim Hüftgelenksersatz mit Heparin und Dihydroergotamin. Münch Med Wschr 1979; 36: 1152-4.
    PubMedSearch in Google Scholar
  • 56 Kakkar V V, Djazaeri B, Fok J, Fletcher M, Scully M F, Westwick J. Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 1982; 284: 375-9.
    CrossrefPubMedSearch in Google Scholar
  • 57 Kakkar V V. Prevention of post-operative venous thromboembolism by a new molecular weight heparin fraction. Nouv Rev Fr Hematol 1984; 26: 277-82.
    PubMedSearch in Google Scholar
  • 58 Kakkar V V, Murray W J G. Efficacy and safety of low-molecular-weight heparin (CY 216) in preventing postoperative venous thrombo-embolism : a co-operative study. Br J Surg 1985; 72: 786-91.
    CrossrefPubMedSearch in Google Scholar
  • 59 Kakkar V V, Kakkar S, Sanderson R M, Peers C E. Efficacy and safety of two regimens of low molecular weight heparin fragment (fragmin) in preventing postoperative venous thromboembolism. Haemostasis 1986; 16 (Suppl. 02) 19-24.
    PubMedSearch in Google Scholar
  • 60 Koller M, Schoch U, Buchmann P, Largiadèr F, von Felten A, Frick P G. Thrombosis prophylaxis in visceral surgery with the low molecular weight heparin fragment Kabi 2165 (7,500 and 2,500 anti-Xa IU/ day). Haemostasis 1986; 16 (Suppl. 02) 69-70.
    PubMedSearch in Google Scholar
  • 61 Lam L H, Silbert J E, Rosenberg R D. The separation of active and inactive forms of heparin. Biochem Biophys Res Commun 1976; 69: 570-7.
    CrossrefPubMedSearch in Google Scholar
  • 62 Lane D A, Flynn A, Ireland H, Anastassiades E, Curtis J R. On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure. Haemostasis 1986; 16 (Suppl. 02) 38-47.
    PubMedSearch in Google Scholar
  • 63 Laurent T C. Studies on fractionated heparin. Arch Biochem Biophys 1961; 92: 224-31.
    CrossrefPubMedSearch in Google Scholar
  • 64 Laurent T C, Killander J. A theory of gel filtration and its experimental verification. J Chromatogr 1964; 14: 317-30.
    CrossrefPubMedSearch in Google Scholar
  • 65 Linhardt R J, Grant A, Cooney C L, Langer R. Differential anticoagulant activity of heparin fragments prepared using microbial heparinase. J Biol Chem 1982; 257: 7310-3.
    PubMedSearch in Google Scholar
  • 66 MacGregor I R, Lane D A, Kakkar V V. The anti-heparin properties of human lowdensity lipoprotein. Biochem Biophys Acta 1980; 617: 472-9.
    CrossrefPubMedSearch in Google Scholar
  • 67 Mardiguian J, Trillou M. Studies on heparin octadecasaccharide fragments. Thromb Haemost 1983; 50: 223 (Abstr).
    PubMedSearch in Google Scholar
  • 68 Maroske D. Wirkungsprüfung von niedermolekularem Heparin in fixer Kombination mit Dihydroergotamin und HeparinDHE® in der Traumatologie. Gutachten für B G A/Zulassungsdossier; 1985
    Search in Google Scholar
  • 69 Mattsson C, Hoylaerts M, Holmer E, Uthne T, Collen D. Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III. J Clin Invest 1985; 75: 1169-73.
    CrossrefPubMedSearch in Google Scholar
  • 70 Merton R E, Thomas D P, Havercroft S J, Barrowcliffe T W, Lindahl U. High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs. Thromb Haemost 1984; 51: 254-6.
    Thieme ConnectPubMedSearch in Google Scholar
  • 71 Neerstrand H, Hedner U, Ostergaard P, Bergqvist D, Mätzsch T. t-PA inhibitor, tPA: AG, and plasminogen after low molecular weight heparin or standard heparin. Fibrinolysis. Abstr. 178, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 72 Ockelford P A, Carter C J, Cerskus A, Smith C A, Hirsh J. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction. Thromb Res 1982; 27: 679-90.
    CrossrefPubMedSearch in Google Scholar
  • 73 Ockelford P A, Charter C J, Mitchell L, Hirsh J. Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction. Thromb Res 1983; 28: 401-9.
    PubMedSearch in Google Scholar
  • 74 Oosta G M, Gardner W T, Beeler D L, Rosenberg R D. Multiple functional domains of the heparin molecule. Proc Natl Acad Sci 1981; 75: 829-33.
    PubMedSearch in Google Scholar
  • 75 Racanelli A, Fareed J, Walenga J M, Coyne E. Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragments. Sem Thromb Hemost 1985; 11: 176-89.
    Thieme ConnectPubMedSearch in Google Scholar
  • 76 Rosenberg R D. Actions and interactions of antithrombin and heparin. New Engl J Med 1975; 292: 146-51.
    CrossrefPubMedSearch in Google Scholar
  • 77 Rosenberg R D, Armand G, Lam L. Structure-function relationships of heparin species. Proc Natl Acad Sei USA 1978; 75: 3065-9.
    CrossrefPubMedSearch in Google Scholar
  • 78 Rosenberg R D, Jordan R E, Favreau L V, Lam L H. Highly active heparin species with multiple binding sites for antithrombin. Biochem Biophys Res Commun 1979; 86: 1319-24.
    CrossrefPubMedSearch in Google Scholar
  • 79 Rosenberg R D, Lam L. Correlation between structure and function of heparin. Proc Natl Acad Sei USA 1979; 76: 1218-22.
    CrossrefPubMedSearch in Google Scholar
  • 80 Roussi J, Houbouyan L, Rosenthal D, Toulemonde F, Goguel A. Succès du traitement par une fraction d’héparine de bas poids moléculaire dans un cas d’embolie pulmonaire compliquant une thrombopénie induite par l’héparine. Nouv Rev Fr Hématol 1983; 25: 273-4.
    PubMedSearch in Google Scholar
  • 81 Roussi J H, Houbouyan L L, Goguel A F. Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications. Lancet 1984; I 8387 1183.
    PubMedSearch in Google Scholar
  • 82 Rutilant M L, Fontcuberta J, MartmezJubitero J M, Borrell M. The influence of low molecular weight heparin (LMWH) or standard heparin (UFH) on fibrinolysis. Fibrinolysis. Abstr. 205, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 83 Rutilant M L, Fontcuberta J, MartmezJubitero J M, Cairols M, Rosendo A. Treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH, CY-216 Choay) compared to standard heparin (UFH). Fibrinolysis. Abstr. 346, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 84 Rutilant M L, Fontcuberta J, MartmezJubitero J M, Cairols M, Rosendo A. Subcutaneous low molecular weight heparin (LMWH Kabi-2165) or unfractionated heparin (UFH) in the treatment of deep venous thrombosis (DVT). Fibrinolysis. Abstr. 350, 8th Internat. Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 85 Salzman E W, Rosenberg R D, Smith M H, Lindon J N, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65: 64-73.
    CrossrefPubMedSearch in Google Scholar
  • 86 Sasahara A A, Koppenhagen K, Färing R, Welzel D, Wolf H. Low molecular weight heparin + dihydroergotamine for prophylaxis of post operative deep vein thrombosis. Br J Surg 1986; 73: 697-700.
    CrossrefPubMedSearch in Google Scholar
  • 87 Silane M, Lindon J N, Ransil B J, Rosenberg R D, Salzman E W. Platelet aggregation induced in vivo by heparin and heparin fractions. Thromb Haemost 1981; 46: 194 (Abstr).
    Thieme ConnectPubMedSearch in Google Scholar
  • 88 de Swart C A M, Sixma J J, Nijmeijer A, Holmer E, Andersson L O, Verschoor L. Kinetics of anticoagulant and lipolytic activity and radiolabel after intravenous administration of 35 S-heparin fractions of different molecular weight. Thromb Haemost 1981; 46: 185 (Abstr).
    Thieme ConnectPubMedSearch in Google Scholar
  • 89 Schmitz-Hübner U, Balleisen L, Asbeck F, van de Loo J. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. - I. Effects of heparin fractions. Thromb Haemost 1981; 46: 612-6.
    Thieme ConnectPubMedSearch in Google Scholar
  • 90 Schmitz-Hübner U. Gerinnungsphysiologische Wirkungen niedrigdosierten Heparins, fraktionierten Heparins und verwandter Mucopolysaccharide. Habilitationsschr. Münster; 1982
    Search in Google Scholar
  • 91 Schrader J, Kandt M, Zürcher C, Köstering H, Scheler F. Comparison of unfractionated heparin and low molecular weight heparin during long-term use in chronic haemodialysis and haemofiltration patients. Haemostasis 1986; 16 (Suppl. 02) 48-58.
    PubMedSearch in Google Scholar
  • 92 Stone A L, Beeler D, Oosra G, Rosenberg R D. Circular dichroism spectroscopy of heparin-antithrombin interactions. Proc Natl Acad Sei USA 1982; 79: 7190-4.
    CrossrefPubMedSearch in Google Scholar
  • 93 Thomas D P, Merton R E, Lewis W E, Barrowcliffe T W. Studies on man and experimental animals of a low molecular weight heparin fraction. Thromb Haemost 1981; 45: 214-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 94 Thomas D P, Merton R E, Barrowcliffe T W, Thunberg L, Lindahl U. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis. Thromb Haemost 1982; 47: 244-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 95 Thomson C, Forbes C D, Prentice C R M. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med 1973; 45: 485-94.
    PubMedSearch in Google Scholar
  • 96 Tscherne H, Westermann K, Trentz O, Pretschnow P, Mellmann J. Thromboembolische Komplikationen und ihre Prophylaxe beim Hüftgelenkersatz. Unfallheilkunde 1978; 81: 178-87.
    PubMedSearch in Google Scholar
  • 97 Vairel E G, Bouty-Boye H, Toulemonde F, Doutremepuich C, Marsh N A, Gaffney P J. Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis. Thromb Res 1983; 30: 219-24.
    CrossrefPubMedSearch in Google Scholar
  • 98 Vergnes C, Janvier G, Winnock S, Lorient M FRoudaut, Freyburger G, Crocket J, Bosseau M R. Treatment of deep venous thrombosis with CY 222: biologic data. Fibrinolysis. Abstr 182. 8th Internat Congress on Fibrinolysis: Vienna; 1986
    Search in Google Scholar
  • 99 Vinazzer H, Stemberger A, Haas S. Effect of heparin fractions and of low molecular weight heparin-like substances on fibrinolysis. Haemostasis 1982; 12: 123.
    PubMedSearch in Google Scholar
  • 100 Vinazzer H, Stemberger A, Haas S, Blümel G. Influence of heparin, of different heparin fractions and of low molecular weight heparin-like substance on the mechanism of fibrinolysis. Thromb Res 1982; 27: 341-52.
    CrossrefPubMedSearch in Google Scholar
  • 101 Wessler S, Reimer S M, Sheps M C. Biologic assay of a thrombosis inducing activity in human serum. J Appl Physiol 1959; 14: 943-6.
    CrossrefPubMedSearch in Google Scholar
  • 102 Yin E T. Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-II globulin inhibitor. Thromb Diathes Haemorrh 1975; 33: 43-50.
    PubMedSearch in Google Scholar
  • 103 Zimmermann R, Harenberg J. Gutachten für BGA/Zulassungsdossier. 1985
    PubMedSearch in Google Scholar